Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.295 AUD 1.72% Market Closed
Market Cap: 85.1m AUD

Intrinsic Value

RCE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RCE stock under the Base Case scenario is 0.043 AUD. Compared to the current market price of 0.295 AUD, Recce Pharmaceuticals Ltd is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RCE Intrinsic Value
0.043 AUD
Overvaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Recce Pharmaceuticals Ltd

Valuation History Unavailable

Historical valuation for RCE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Recce Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Recce Pharmaceuticals Ltd

Current Assets 3m
Cash & Short-Term Investments 2.2m
Receivables 494.4k
Other Current Assets 283.8k
Non-Current Assets 1.2m
PP&E 1.2m
Efficiency

Free Cash Flow Analysis
Recce Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Recce Pharmaceuticals Ltd

Revenue
9.8m AUD
Operating Expenses
-26.5m AUD
Operating Income
-16.6m AUD
Other Expenses
-1.3m AUD
Net Income
-17.9m AUD
Fundamental Scores

RCE Profitability Score
Profitability Due Diligence

Recce Pharmaceuticals Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional ROIC
ROE is Increasing
40/100
Profitability
Score

Recce Pharmaceuticals Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

RCE Solvency Score
Solvency Due Diligence

Recce Pharmaceuticals Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
56/100
Solvency
Score

Recce Pharmaceuticals Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCE Price Targets Summary
Recce Pharmaceuticals Ltd

There are no price targets for RCE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Recce Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for RCE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RCE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RCE stock?

The intrinsic value of one RCE stock under the Base Case scenario is 0.043 AUD.

Is RCE stock undervalued or overvalued?

Compared to the current market price of 0.295 AUD, Recce Pharmaceuticals Ltd is Overvalued by 86%.

Back to Top